Neuroscience session-1: Psychedelics in Depression: Friend or Foe?
Tracks
Track 5
| Thursday, June 4, 2026 |
| 9:00 AM - 10:30 AM |
Speaker
Albino J. Oliveira-Maia
Director
Champalimaud Foundation
Beyond trials in psychedelic medicine: ethics, implementation and equity
9:00 AM - 9:30 AMBiography
Albino J. Oliveira Maia, MD, MPH, PhD.
Albino J. Oliveira Maia trained in medicine at the Faculty of Medicine of the University of Porto, and then did doctoral and post-doctoral work in Neuroscience at Duke University and the Champalimaud Foundation, and completed a master’s degree in public health at Harvard University. After academic training, Albino specialized in Psychiatry and worked as a Psychiatrist in Lisbon. He is currently Director of the Neuropsychiatry Unit at the Champalimaud Clinical Center, Director of the Digital Neurotherapeutics Centre at the Centre for Restorative Neurotechnology, PI at the Neuroscience of Disease Programme, and professor of Psychiatry and Neuroscience at NOVA Medical School in Lisbon. Albino is also coordinator of the Psychiatry Working Group at the Office for the National Exam for Access to Specialty Training (Portugal), President-elect of the Portuguese Society of Psychiatry and Mental Health, President of the Scientific Council for the Portuguese OCD Foundation and President of the Ethics Committee at the Institute for Addictive Behaviors and Addictions.
Luisa Pinto
Targeting Adult Hippocampal Cytogenesis: Psilocybin's Role in Depression Therapy
9:30 AM - 10:00 AMBiography
Inês Almeida
Phd Student
Nova Medical School-nova University Of Lisbon
Carotid body ablation improved non-motor dysfunction in a mouse model of Parkinson's disease
10:00 AM - 10:15 AMBiography
Gabriela Ribeiro
Assistant Professor
Nova Medical School, Faculdade De Ciências Médicas
Linking metabolic state to sweet taste perception: influence of food reward sensitivity.
10:15 AM - 10:30 AMBiography
Chair
Luisa Pinto
Rita Teodoro
